Axsome Therapeutics (AXSM) News Today $101.12 +0.71 (+0.71%) As of 03:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AXSM Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Axsome Therapeutics (AXSM) to Release Earnings on MondayJuly 28 at 6:16 AM | marketbeat.comRoyce & Associates LP Reduces Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 28 at 4:08 AM | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Makes New Investment in Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 28 at 3:47 AM | marketbeat.comCwm LLC Trims Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 28 at 3:17 AM | marketbeat.comEnvestnet Asset Management Inc. Sells 10,086 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 28 at 3:07 AM | marketbeat.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Sold by Knights of Columbus Asset Advisors LLCJuly 27 at 5:49 AM | marketbeat.comQ3 EPS Estimate for Axsome Therapeutics Increased by AnalystJuly 25, 2025 | americanbankingnews.comWilliam Blair Issues Positive Forecast for AXSM EarningsJuly 24, 2025 | marketbeat.com2 Top Stocks I Wouldn't Hesitate to Invest $1,000 in Right NowJuly 24, 2025 | fool.comLegato Capital Management LLC Buys New Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 24, 2025 | marketbeat.comY Intercept Hong Kong Ltd Purchases New Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 24, 2025 | marketbeat.comAxsome Therapeutics (NASDAQ:AXSM) Trading Down 5.6% - Here's What HappenedJuly 23, 2025 | marketbeat.comReadystate Asset Management LP Invests $6.95 Million in Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 22, 2025 | marketbeat.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) is Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.'s 4th Largest PositionJuly 22, 2025 | marketbeat.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Purchased by New York State Common Retirement FundJuly 22, 2025 | marketbeat.comAxsome Therapeutics Hosts Frontiers in Brain Health R&D Day Reviewing Industry-Leading Late-Stage CNS PipelineJuly 21, 2025 | financialpost.comFAxsome Therapeutics Hosts Frontiers in Brain Health R&D Day Reviewing Industry-Leading Late-Stage CNS PipelineJuly 21, 2025 | globenewswire.comAnalysts Are Bullish on These Healthcare Stocks: Axsome Therapeutics (AXSM), Enliven Therapeutics (ELVN)July 20, 2025 | theglobeandmail.comLindbrook Capital LLC Decreases Stock Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 20, 2025 | marketbeat.comBank of New York Mellon Corp Has $15.28 Million Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 20, 2025 | marketbeat.comEquities Analysts Offer Predictions for AXSM Q2 EarningsJuly 16, 2025 | marketbeat.comEdgestream Partners L.P. Takes Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 14, 2025 | marketbeat.comLeerink Partnrs Issues Optimistic Forecast for AXSM EarningsJuly 14, 2025 | marketbeat.comAXSM - Axsome Therapeutics Inc Executives | MorningstarJuly 12, 2025 | morningstar.comMBank of America Securities Keeps Their Buy Rating on Axsome Therapeutics (AXSM)July 12, 2025 | theglobeandmail.comAlps Advisors Inc. Sells 6,826 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 12, 2025 | marketbeat.comAxsome Therapeutics Inc News (AXSM) - Investing.comJuly 11, 2025 | investing.comStocks Showing Improving Market Leadership: Axsome Therapeutics Earns 85 RS RatingJuly 10, 2025 | msn.comAxsome Therapeutics (AXSM) Initiated with a Buy at OppenheimerJuly 9, 2025 | theglobeandmail.comIridian Asset Management LLC CT Has $12.40 Million Stock Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 9, 2025 | marketbeat.comAxsome Therapeutics to Report Second Quarter 2025 Financial Results on August 4July 9, 2025 | globenewswire.comAxsome Therapeutics (AXSM) Gets a Buy from Wells FargoJuly 9, 2025 | theglobeandmail.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) Given Average Recommendation of "Buy" by BrokeragesJuly 9, 2025 | marketbeat.comTrek Financial LLC Invests $3.45 Million in Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 8, 2025 | marketbeat.comPenserra Capital Management LLC Buys Shares of 19,112 Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 8, 2025 | marketbeat.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Purchased by Principal Financial Group Inc.July 8, 2025 | marketbeat.comAxsome Therapeutics to Showcase Its Innovative CNS Pipeline at Upcoming Frontiers in Brain Health R&D Day in New York City on July 21July 7, 2025 | globenewswire.comMoody Aldrich Partners LLC Has $7.27 Million Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 4, 2025 | marketbeat.comPiper Sandler Reaffirms Price Target on Axsome (AXSM) Despite AXS-14 FDA HurdleJuly 4, 2025 | msn.comAxsome Therapeutics (NASDAQ:AXSM) Coverage Initiated at Morgan StanleyJuly 3, 2025 | marketbeat.comZacks Research Issues Pessimistic Outlook for AXSM EarningsJuly 3, 2025 | marketbeat.comZacks Research Issues Pessimistic Forecast for AXSM EarningsJuly 2, 2025 | marketbeat.comPeregrine Capital Management LLC Sells 27,466 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 1, 2025 | marketbeat.comLisanti Capital Growth LLC Acquires Shares of 33,280 Axsome Therapeutics, Inc. (NASDAQ:AXSM)June 29, 2025 | marketbeat.comAXSM - Axsome Therapeutics Inc Ownership - MorningstarJune 27, 2025 | morningstar.comMInsider Selling: Axsome Therapeutics, Inc. (NASDAQ:AXSM) General Counsel Sells 6,014 Shares of StockJune 24, 2025 | insidertrades.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) General Counsel Hunter R. Murdock Sells 6,014 SharesJune 23, 2025 | marketbeat.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) General Counsel Hunter R. Murdock Sells 7,500 SharesJune 23, 2025 | marketbeat.comAxsome Therapeutics Champions Brain Health During Alzheimer's & Brain Awareness MonthJune 20, 2025 | globenewswire.comHunter R. Murdock Sells 7,500 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) StockJune 19, 2025 | insidertrades.com Get Axsome Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AXSM and its competitors with MarketBeat's FREE daily newsletter. Email Address AXSM Media Mentions By Week AXSM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AXSM News Sentiment▼1.241.04▲Average Medical News Sentiment AXSM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AXSM Articles This Week▼1611▲AXSM Articles Average Week Get Axsome Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AXSM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies JAZZ News INSM News TEVA News GMAB News MRNA News RDY News QGEN News VTRS News ASND News VRNA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AXSM) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thNew China tariffs hit August 12th—and Wall Street’s already moving. Banks and billionaires are quietly shif...American Alternative | SponsoredStrange Investment Secret Predicts Market's Next Move?A strange market signal discovered before the Great Depression has predicted nearly every major financial even...Weiss Ratings | SponsoredThe $1 Trillion Event Tesla Still Hasn’t Recovered FromIn 2010, a “Flash Crash” erased $1 trillion in minutes. Now, one trading legend says it’s happening again—insi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Axsome Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Axsome Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
